title: Flemish and Dutch mutations in amyloid beta precursor protein have different effects on amyloid beta secretion.
abstract: Mutations in the amyloid beta precursor protein (APP) gene cosegregate with autosomal dominant Alzheimer disease (AD). Brain pathology of AD is characterized by amyloid deposition in senile plaques and by neurofibrillary tangles. Amyloid deposits in AD brains consist of amyloid beta (A beta), a 4-kDa proteolytic product of APP. In contrast, two other mutations in APP, the Flemish APP692 and Dutch APP693 mutations, are associated with autosomal dominant cerebral hemorrhages due to congophilic amyloid angiopathy (CAA) in the presence or absence of AD pathology, respectively. Both mutations are located within A beta near the constitutive cleavage site. While a common effect of AD-linked mutations is to elevate A beta 42 extracellular concentrations, not much is known about the effect of APP692 and APP693. Here we provide evidence that APP692 and APP693 have a different effect on A beta secretion as determined by cDNA transfection experiments. While APP692 upregulates both A beta 40 and A beta 42 secretion, APP693 does not. These data corroborate with previous findings that increased A beta secretion and particularly of A beta 42, is specific for AD pathology.
authors.affiliation: Flanders Interuniversity Institute for Biotechnology, Born-Bunge Foundation, University of Antwerp (UIA), Department of Biochemistry, Belgium.
authors.forename: C
authors.initials: C
authors.lastname: De Jonghe
authors.forename: C
authors.initials: C
authors.lastname: Zehr
authors.forename: D
authors.initials: D
authors.lastname: Yager
authors.forename: C M
authors.initials: CM
authors.lastname: Prada
authors.forename: S
authors.initials: S
authors.lastname: Younkin
authors.forename: L
authors.initials: L
authors.lastname: Hendriks
authors.forename: C
authors.initials: C
authors.lastname: Van Broeckhoven
authors.forename: C B
authors.initials: CB
authors.lastname: Eckman
mesh_terms: D000595:Amino Acid Sequence; D016229:Amyloid beta-Peptides / Q000378:metabolism*; D016564:Amyloid beta-Protein Precursor / Q000235:genetics* / Q000378:metabolism; D000818:Animals; D016466:CHO Cells / Q000166:cytology / Q000378:metabolism; D002460:Cell Line; D006224:Cricetinae; D018076:DNA, Complementary / Q000235:genetics; D006801:Humans; D008969:Molecular Sequence Data; D009154:Mutation; D010446:Peptide Fragments / Q000378:metabolism; D010957:Plasmids / Q000235:genetics; D011993:Recombinant Fusion Proteins / Q000235:genetics; D014162:Transfection; D014407:Tumor Cells, Cultured / Q000166:cytology / Q000378:metabolism
chemical_list: D016229:Amyloid beta-Peptides; D016564:Amyloid beta-Protein Precursor; D018076:DNA, Complementary; D010446:Peptide Fragments; D011993:Recombinant Fusion Proteins; C078592:amyloid beta-protein (1-40); C075222:amyloid beta-protein (1-42)